EGI
AVEO

EAM Global Investors’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

EAM Global Investors’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-211,759
Closed -$1.74M – 261
2022
Q3 		$1.74M Buy
+211,759
New +$1.63M 0.46% 98
2018
Q2 		– Sell
-24,477
Closed -$710K – 202
2018
Q1 		$710K Hold
24,477
– – 0.37% 129
2017
Q4 		$683K Buy
+24,477
New +$760K 0.35% 126

Other funds holding AVEO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

EAM Global Investors's AVEO Position: Q4 2022 in Review

EAM Global Investors sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 211,759 shares — an estimated $1.74M sold.

EAM Global Investors first reported a position in AVEO in Q4 2017 and held it in 3 quarters. The position peaked at $1.74M in Q3 2022. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

  • EAM Global Investors reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
  • EAM Global Investors sold 211,759 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $1.74M.
  • EAM Global Investors first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2017 and held it in 3 quarters.
  • EAM Global Investors's AVEO Pharmaceuticals, Inc. position peaked at $1.74M in Q3 2022.
  • 110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on EAM Global Investors's 13F filing for Q4 2022, filed 14 Feb 2023.